Coccidioides immitis is a thermally dimorphic fungal pathogen responsible for coccidioidomycosis, commonly known as Valley Fever. This endemic fungal infection is characterized by a rising incidence and expanding geographic range across semiarid regions of the Western Hemisphere . The fungus demonstrates a complex life cycle, growing as mycelia in soil but transitioning to pathogenic spherules when inhaled into mammalian lungs . This morphological transition is accompanied by large-scale transcriptional reprogramming that facilitates the pathogen's adaptation to the host environment.
Assembly factor CBP4, also known as Cytochrome b mRNA-processing protein 4, is encoded by the CBP4 gene (CIMG_10084) in the C. immitis genome . This protein represents one component of the complex molecular machinery involved in the fungal pathogen's biological processes.
Recombinant C. immitis Assembly factor CBP4 protein is typically produced using bacterial expression systems. The most common approach involves expressing the protein in Escherichia coli with an N-terminal histidine (His) tag to facilitate purification . This expression system allows for efficient production of the protein for research and analytical purposes.
The expression construct contains the full-length coding sequence (1-111 amino acids) of the CBP4 gene, enabling the production of the complete functional protein .
Table 1: Standard Purification Protocol for Recombinant CBP4
| Step | Procedure | Details |
|---|---|---|
| 1 | Expression | Recombinant protein expressed in E. coli with N-terminal His tag |
| 2 | Cell Lysis | Bacterial cells disrupted to release expressed protein |
| 3 | Affinity Chromatography | His-tagged protein isolated using nickel or cobalt resins |
| 4 | Quality Control | Purity assessment by SDS-PAGE (typically >90% purity) |
| 5 | Lyophilization | Conversion to stable lyophilized powder form |
The purified protein is typically analyzed by SDS-PAGE to confirm its purity, which generally exceeds 90% .
The name "Assembly factor CBP4" suggests a role in molecular assembly processes within the fungal cell. The alternative name "Cytochrome b mRNA-processing protein 4" indicates potential involvement in the processing of cytochrome b mRNA, suggesting a role in mitochondrial function and energy metabolism .
In the context of C. immitis biology, the transition from soil-dwelling mycelia to pathogenic spherules in the host involves massive transcriptional reprogramming and metabolic adjustments . During this morphological transition, gene expression patterns change dramatically to adapt to the new environment and evade host immune responses.
While the specific role of CBP4 in C. immitis pathogenesis has not been explicitly detailed in the available research, proteins involved in mitochondrial function and energy metabolism are often critical for pathogen survival and adaptation within host environments .
The morphological transition of C. immitis from mycelia to spherules, which is essential for its pathogenicity, depends on complex transcriptional networks and regulatory mechanisms . Understanding the function of proteins like CBP4 may provide insights into the pathogen's ability to establish infection and cause disease.
Coccidioidomycosis is an occupational disease affecting workers exposed to outdoor dust containing fungal spores . Additionally, individuals with compromised T-cell immunity, the elderly, and certain racial groups (particularly African-Americans and Filipinos) residing in endemic regions of the southwestern United States have an elevated risk of symptomatic infection .
As climate change continues to alter environmental conditions, models predict an expansion of endemic areas and a significant increase in Valley Fever cases . This underscores the importance of understanding the molecular biology of C. immitis, including the role of proteins like CBP4.
Efforts to develop vaccines against coccidioidomycosis have focused primarily on recombinant protein vaccines . While CBP4 itself has not been specifically identified as a vaccine candidate in the available research, studies on recombinant C. immitis proteins have shown varying degrees of success in stimulating protective immune responses .
A genetically engineered, live, attenuated vaccine has demonstrated protection in mouse models against coccidioidomycosis . Further research into proteins involved in the fungal life cycle, potentially including CBP4, may contribute to improved vaccine design strategies.
Table 2: Potential Research Applications for Recombinant CBP4
| Application | Description | Relevance |
|---|---|---|
| Antibody Production | Generation of anti-CBP4 antibodies | Detection and localization studies |
| Functional Studies | Analysis of protein interactions and enzymatic activities | Understanding metabolic pathways |
| Diagnostic Development | Potential use in immunoassays | Identification of C. immitis infection |
| Structural Biology | Crystallography and structural analysis | Determination of protein function |
| Drug Target Validation | Screening of inhibitory compounds | Development of antifungal agents |
The availability of recombinant CBP4 enables researchers to investigate its structure, function, and potential applications in diagnostics or therapeutics for coccidioidomycosis .
Future research could investigate the role of CBP4 in the transcriptional reprogramming that occurs during the transition from mycelia to spherules in C. immitis. The application of advanced techniques such as capped small (cs)RNA-seq, which identifies actively initiated stable and unstable transcripts, could provide insights into the regulatory networks involving CBP4 .
Identifying protein-protein interactions involving CBP4 could elucidate its role in fungal biology and potentially reveal new targets for antifungal drug development. Techniques such as co-immunoprecipitation, yeast two-hybrid screening, or proximity labeling could be employed to map the interaction network of CBP4 .
Essential for the assembly of ubiquinol-cytochrome c reductase. It directly influences the correct incorporation of the Rieske protein, core 4, core 5, and apocytochrome b.
KEGG: cim:CIMG_10084
Gene expression analysis indicates that many genes in C. immitis exhibit differential expression between the saprobic (hyphal) and parasitic (spherule) growth phases. While specific CBP4 expression data is not explicitly detailed in the provided studies, the comparative transcriptomics approach used by researchers has identified 1,298 genes up-regulated in the saprobic phase and 1,880 genes up-regulated in the parasitic phase across both C. immitis and C. posadasii .
To determine CBP4's specific expression pattern, researchers typically use RNA-seq analysis of actively-growing hyphae (saprobic phase) and pre-endosporulation spherules (parasitic phase) cultured for 96 hours in vitro. This methodology allows for the identification of genes potentially involved in the dimorphic transition, which is critical for pathogenesis .
The CBP4 gene in C. immitis is located in the genome with ORF name CIMG_10084 . The protein contains specific domains characteristic of assembly factors and has a predicted molecular function related to mitochondrial transcript processing.
In the context of the Coccidioides genome:
C. immitis RS genome has been fully sequenced and assembled into seven contigs, totaling 28.9 Mb with 10,355 annotated genes
The genomic context is important, as the GC content of regions can affect gene expression, with repetitive regions having 14-15% lower GC content than non-repetitive sequences
For the production of recombinant CBP4 protein:
Expression System Selection: While specific conditions for CBP4 aren't detailed in the search results, recombinant proteins from C. immitis are typically expressed in bacterial systems like E. coli or eukaryotic systems depending on the requirement for post-translational modifications .
Purification Protocol:
The recombinant protein is typically stored in Tris-based buffer with 50% glycerol
Optimal storage conditions include -20°C for standard storage and -80°C for extended storage
Working aliquots can be maintained at 4°C for up to one week
Repeated freezing and thawing should be avoided to maintain protein integrity
Tag Selection: The tag type for the recombinant protein will be determined during the production process and should be optimized based on the specific experimental requirements .
To validate recombinant CBP4 functionality:
Structural Validation:
Confirm protein identity through mass spectrometry
Verify protein folding using circular dichroism or limited proteolysis
Use size exclusion chromatography to assess oligomerization state
Functional Assays:
Develop in vitro assays to measure cytochrome b mRNA processing activity
Assess binding interactions with target RNAs using electrophoretic mobility shift assays
Compare activity with native protein isolated from C. immitis if possible
Cellular Complementation:
Test the ability of recombinant CBP4 to complement function in CBP4-knockout models
Assess restoration of phenotypes in mutant strains
The validation approach should incorporate controls that account for potential differences between recombinant and native proteins, particularly regarding post-translational modifications.
Comparative analysis of C. immitis and C. posadasii genomes reveals:
Genomic Context:
Both species have similar genome sizes (C. immitis RS: 28.9 Mb, C. posadasii C735: 27 Mb)
Despite similar genome sizes, there are differences in annotated genes (C. immitis: 10,355, C. posadasii: 7,229)
Of the non-repetitive sequence, 93.5% exhibits homology between species with a median sequence identity of 98.3%
Species-Specific Genes:
Evolutionary Patterns:
Understanding these differences is crucial for interpreting CBP4 function in the context of both species and their pathogenic potential.
The evolutionary significance of CBP4 can be analyzed through several lenses:
Conservation Pattern:
If CBP4 is highly conserved between species, it likely serves a fundamental cellular function
Conservation across Coccidioides species suggests evolutionary pressure to maintain this function
Introgression Analysis:
Selection Pressure:
Transposable Element Influence:
Recent advances in CRISPR/Cas9 technology for Coccidioides provide a methodology framework:
Double-Cut CRISPR/Cas9 Approach:
Implementation Strategy:
Design guide RNAs targeting regions flanking the CBP4 gene
Create a repair template containing a selectable marker (e.g., hygromycin resistance gene) with homology arms
Assemble CRISPR/Cas9 components in vitro before transformation
Transform C. immitis protoplasts with the assembled components
Select transformants on hygromycin-containing media
Validation Methods:
Confirm gene deletion using PCR with primers flanking the target region
Verify deletion using Southern blot analysis
Analyze phenotypic changes in both saprobic and parasitic growth phases
This approach would allow for the characterization of CBP4's role in C. immitis biology and potentially identify its contribution to pathogenesis .
Transcriptomic analysis offers powerful insights into CBP4 function during the dimorphic transition:
RNA-seq Analysis:
csRNA-seq Approach:
Capped small RNA sequencing (csRNA-seq) has been used to identify transcription start regions (TSRs) in C. immitis
This technique reveals alternative promoter usage and regulatory mechanisms associated with pathogenic growth
Application to CBP4 could identify its transcription start sites and regulatory elements
Methodology Framework:
Isolate RNA from different growth phases: mycelia (saprobic) and spherules (parasitic)
Perform csRNA-seq to identify TSRs associated with CBP4
Analyze bidirectional transcription and promoter architecture
Identify putative transcription factors regulating CBP4 expression
This approach would provide insights into the regulatory mechanisms controlling CBP4 expression during the critical transition from environmental to pathogenic growth .
Understanding CBP4's potential role in pathogenesis requires integrating multiple data types:
Mitochondrial Function Connection:
As a cytochrome b mRNA processing factor, CBP4 likely influences mitochondrial function
Mitochondrial activity is often reprogrammed during fungal pathogenesis to adapt to host environments
Changes in energy metabolism may support survival under host immune pressure
Expression Pattern Analysis:
If CBP4 shows differential expression between growth phases, this could suggest a specific role in adaptation to the host environment
Comparison with other known virulence factors could position CBP4 within pathogenicity pathways
Host Response Considerations:
Integration with Volatile Organic Compound (VOC) Analysis:
| TE Type | C. immitis | C. posadasii | ||
|---|---|---|---|---|
| Number | Mean Length | Number | Mean Length | |
| DNA/TcMar | 286 | 884 | 575 | 991 |
| DNA/hAT | 100 | 2416 | 37 | 1232 |
| LTR/Gypsy | 1204 | 2089 | 1199 | 2046 |
| LTR/Copia | 287 | 1351 | 190 | 937 |
| LINE | 364 | 1331 | 225 | 1237 |
Impact on Gene Expression:
In C. immitis, genes within 1 kB of Gypsy and hAT transposable elements show significantly reduced expression
Mean expression level of C. immitis genes within 1 kB of a TE is significantly lower (3.60 FPKM) compared to control genes (4.29 FPKM)
Genes near multiple TEs (four or more) show extremely low expression levels
This effect is less pronounced in C. posadasii, though still statistically significant for genes near Gypsy elements
Understanding these patterns is crucial when analyzing the genomic context of CBP4 and interpreting its expression data.
| Feature | C. immitis RS | C. posadasii C735 |
|---|---|---|
| Genome Size | 28.9 Mb | 27 Mb |
| Annotated Genes | 10,355 | 7,229 |
| Homologous Sequence | 22.3 Mb (93.5%) | 22.3 Mb |
| Species-Specific Genes | 282 | 66 |
| GC Content | 46% (average) | 46% (average) |
| GC Content in TEs | 28-39% | 28-39% |
| Repetitive DNA | 17-19% of genome | 17-19% of genome |
Implications for Protein Studies:
Despite differences in annotated gene numbers, 9,996 C. immitis genes have BLASTN hits with >90% identity in C. posadasii
The differences in gene annotation are likely due to different annotation methodologies rather than actual biological differences
When studying proteins like CBP4, researchers should consider the high degree of similarity between species, while accounting for potential species-specific variations
This comparative data provides essential context for researchers studying C. immitis proteins, helping to interpret cross-species conservation and divergence.
Several cutting-edge approaches could advance CBP4 research:
Cryo-EM Structural Analysis:
Determining the three-dimensional structure of CBP4 alone and in complex with its RNA targets
Revealing mechanistic insights into how CBP4 interacts with cytochrome b mRNA
Single-Cell Transcriptomics:
Analyzing CBP4 expression at the single-cell level during the dimorphic transition
Identifying cell-to-cell variation in expression patterns that might be missed in bulk analyses
Proximity Labeling Proteomics:
Using BioID or APEX2 fusions with CBP4 to identify interacting protein partners
Mapping the protein interaction network to place CBP4 in its functional context
CRISPR Interference/Activation:
Using CRISPRi/CRISPRa to modulate CBP4 expression without complete gene deletion
Studying dose-dependent effects on mitochondrial function and pathogenesis
These approaches would complement existing methodologies and provide more nuanced understanding of CBP4's role in C. immitis biology.
Host-pathogen interaction studies could reveal new dimensions of CBP4 function:
Infection Models:
Mouse models have been used to study Coccidioides infection and immune responses
Comparing infection outcomes between wild-type and CBP4-modified strains could reveal its contribution to virulence
Analysis of bronchoalveolar lavage fluid (BALF) from infected mice could identify host responses specific to CBP4
Immune Recognition:
Investigating whether CBP4 is recognized by host immune receptors
Analyzing whether it triggers specific cytokine responses
Comparative Virulence:
Volatile Organic Compound (VOC) Analysis:
These approaches would position CBP4 within the broader context of C. immitis pathogenesis and potentially identify new therapeutic targets.
Ensuring the quality and consistency of recombinant CBP4 preparations requires:
Purity Assessment:
SDS-PAGE with Coomassie staining to verify protein size and purity
Western blot with tag-specific or CBP4-specific antibodies for identity confirmation
Mass spectrometry for accurate molecular weight determination and sequence verification
Structural Integrity:
Circular dichroism to assess secondary structure elements
Dynamic light scattering to evaluate homogeneity and aggregation state
Limited proteolysis to verify domain folding
Storage Stability:
Functional Activity:
Develop and validate assays for cytochrome b mRNA processing activity
Include positive controls from related proteins with known activity
Establish dose-response relationships to ensure activity is proportional to protein concentration
These measures ensure that experimental results accurately reflect CBP4 biology rather than artifacts of protein preparation.
When designing gene expression studies focusing on CBP4:
Growth Phase Selection:
RNA Extraction Optimization:
Develop protocols that efficiently lyse both hyphal and spherule forms
Ensure RNA integrity is maintained throughout the extraction process
Include DNase treatment to remove genomic DNA contamination
Expression Analysis Approaches:
Data Analysis Considerations:
Account for the genomic context of CBP4, particularly its proximity to transposable elements
Consider both absolute expression levels and relative changes between conditions
Use appropriate normalization methods to account for differences in RNA composition between growth phases
These methodological considerations ensure robust and reproducible gene expression data for CBP4 in different biological contexts.